长江流域138家医院1999年～2001年抗肿瘤药物用药分析及其趋势预测

Analysis of Anticancer Drugs Used in 138 Hospitals in the Yangtse Valley of China During the Period 1999～2001 and the Trend Forecast

目的 :对长江流域6城市医院抗肿瘤药物用药的现状和趋势做出客观评估。方法 :调查、分析长江流域6城市138家医院1999年～2001年抗肿瘤药物用药金额、生产企业销售金额、临床应用情况。结果 :抗肿瘤药物用药金额1999年、2000年、2001年分别为19460、24421、32227万元 ,呈逐年上升趋势 ;医院平均每年每床位应用抗肿瘤药物金额为10238元。调查发现 ,一些新的抗肿瘤植物药和单抗药物正在进入市场 ,且基因疗法已在抗肿瘤治疗中初步展示其优势。结论 :抗肿瘤用药在医院占有重要地位,每床位占用金额较多 ,且逐年快速增长 ;抗肿瘤植物药。

OBJECTIVE:To survey and evaluate the present situation and trend of the anticancer drugs used in 6 cities of the Yangtse valley METHODS:The anticancer drugs,used in 138 hospitals of 6 cities in the Yangtse basin during the period 1999～2001,were analysed in respect to the cost,sales volume of pharmaceutical enterprises and situation of clinical application RESULTS:The costs of anticancer drugs consumption were 19 460,24 421 and 32 227 million yuan in 1999,2000 and 2001,respectively with an average annual cost of 10 238 yuan per sickbed Some new anticancer drugs derived from nature plants and monoantibodies were going to the clinical practice And gene therapy has been introduced to the treatment of cancer CONCLUSION:The anticancer drug is an important kind of drugs used in hospitals The cost per sickbed was much high and was increasing year by year Furthermore,the anticancer drugs derived from nature plants,monoantibody and the gene therapy will be the predominant measures in the future